Management Buyout Of PROLOR - Law Firm Seeks Higher Price For Shareholders

  Management Buyout Of PROLOR - Law Firm Seeks Higher Price For Shareholders

PR Newswire

NEW YORK, April 24, 2013

NEW YORK, April 24, 2013 /PRNewswire/ -- Tripp Levy PLLC, a leading national
securities and shareholder rights law firm, announces that it has been
retained to represent shareholders of PROLOR Biotech. OPKO Health, Inc. (OPK)
and PROLOR Biotech, Inc. (NYSE MKT: PBTH) announced that OPKO will acquire
PROLOR, in an all-stock transaction. Phillip Frost, the Chairman and CEO of
OPKO and owner of approx. 40% of OPKO's shares is also the Chairman of the
Board of PROLOR and its largest shareholder of approx. 20% of its shares.

Under the terms of the agreement, holders of PROLOR common stock will receive
0.9951 shares of OPKO common stock for each share of PROLOR common stock.
Based on a price of $7.03 per share of OPKO common stock, the transaction is
valued at approximately $480 million, or $7.00 per share of PROLOR common

The investigation concerns whether Frost and the board of directors of PBTH
breached their fiduciary duties by not engaging in a full and fair auction in
trying to sell the company to obtain the maximum value for shareholders,
rather than sell the Company to Frost for his own personal benefit at an
unfairly low price. As the Chairman and largest shareholder of PBTH, Frost
has an inherent conflict of interest in selling the company to himself.
Indeed, analysts have stated that the true going forward value of PBTH is
worth at least $12 per share.

If you are a shareholder of PBTH and would like additional information
concerning this matter at no cost or obligation, please contact us toll free
at 1-877-772-3975 or email at

Tripp Levy PLLC

Tripp Levy PLLC is a national law firm specializing in shareholder rights and
has recovered millions of dollars for shareholders in similar actions around
the globe.

Press spacebar to pause and continue. Press esc to stop.